CERo Therapeutics Holdings Inc (CERO) concluded trading on Thursday at a closing price of $1.99, with 5.82 million shares of worth about $11.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -87.24% during that period and on January 30, 2025 the price saw a gain of about 2.58%. Currently the company’s common shares owned by public are about 1.48M shares, out of which, 1.04M shares are available for trading.
Stock saw a price change of -15.32% in past 5 days and over the past one month there was a price change of -66.83%. Year-to-date (YTD), CERO shares are showing a performance of -66.83% which decreased to -99.82% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.76 but also hit the highest price of $1280.00 during that period. The average intraday trading volume for CERo Therapeutics Holdings Inc shares is 1.07 million. The stock is currently trading -38.33% below its 20-day simple moving average (SMA20), while that difference is down -78.70% for SMA50 and it goes to -94.37% lower than SMA200.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) currently have 1.48M outstanding shares and institutions hold larger chunk of about 1.49% of that.
The stock has a current market capitalization of $5.44M and its 3Y-monthly beta is at 0.39. It has posted earnings per share of -$43.79 in the same period. It has Quick Ratio of 0.39. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CERO, volatility over the week remained 29.68% while standing at 27.20% over the month.
